Factors influencing participation rates in clinical late-effect studies of childhood cancer survivors.
childhood cancer
childhood cancer survivors
late effects
participation rate
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
revised:
17
03
2021
received:
14
01
2021
accepted:
16
04
2021
pubmed:
23
5
2021
medline:
17
3
2022
entrez:
22
5
2021
Statut:
ppublish
Résumé
To ensure external validation of a study population in clinical late-effect studies of childhood cancer, the participation rate must be high. This study investigated demographic data in Nordic late-effect studies and potential factors impacting participation rates such as cancer type, time since diagnosis, and duration of clinical examinations. We found 80 published studies originating from 16 cohorts, with median follow-up of 6.0 years (range 3-14). The overall participation rates ranged from 27% to 100%. The highest participation rates were seen in studies of survivors with solid tumors (92%) and the lowest in hematologic malignancies (67%) and central nervous system tumors (73%). The clinical examination in 10 studies (62.5%) lasted for more than 3 hours. Neither duration of the clinical examination nor time since diagnosis seemed to affect the participation rate. We encourage future studies to describe the recruitment process more thoroughly to improve understanding of the factors influencing participation rates.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e29098Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Gatta G, Botta L, Rossi S, et al. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study. Lancet Oncol. 2014;15(1):35-47.
Olsen JH, Möller T, Anderson H, et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst. 2009;101(11):806-813.
Bhakta N, Liu Q, Ness KK, et al. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). Lancet. 2017;390(10112):2569-2582.
Armstrong GT, Kawashima T, Leisenring W, et al. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol. 2014;32(12):1218-1227.
Mertens AC, Liu W, Ness KK, et al. Factors associated with recruiting adult survivors of childhood cancer into clinic-based research. Pediatr Blood Cancer. 2014;61(10):1846-1851.
Steele R, Cadell S, Siden H, Andrews G, Quosai TS, Feichtinger L. Impact of research participation on parents of seriously ill children. J Palliat Med. 2014;17(7):788-796.
van Dijk-Lokkart EM, Braam KI, Huisman J, et al. Factors influencing childhood cancer patients to participate in a combined physical and psychosocial intervention program: Quality of Life in Motion. Psychooncology. 2015;24(4):465-471.
Ewing G, Rogers M, Barclay S, et al. Recruiting patients into a primary care based study of palliative care: why is it so difficult? Palliat Med. 2004;18(5):452-459.
Harlan LC, Lynch CF, Keegan THM, et al. Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study. J Cancer Surviv. 2011;5(3):305-314.
Wakefield CE, Fardell JE, Doolan EL, et al. Participation in psychosocial oncology and quality-of-life research: a systematic review. Lancet Oncol. 2017;18(3):e153-e165.
Jarvela LS, Kemppainen J, Niinikoski H, et al. Effects of a home-based exercise program on metabolic risk factors and fitness in long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2012;59(1):155-160.
Einar-Jon E, Trausti O, Asgeir H, et al. Hearing impairment after platinum-based chemotherapy in childhood. Pediatr Blood Cancer. 2011;56(4):631-637.
Molgaard-Hansen L, Skou A-S, Juul A, et al. Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study. Pediatr Blood Cancer. 2013;60(12):1988-1995.
Lofstad GE, Reinfjell T, Weider S, Diseth TH, Hestad K. Neurocognitive outcome and compensating possibilities in children and adolescents treated for acute lymphoblastic leukemia with chemotherapy only. Front Psychol. 2019;10:1027.
Stensvold E, Stadskleiv K, Myklebust TÅ, et al. Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors. Acta Paediatr. 2020;109:1875-1886.
Hess SL, Jóhannsdóttir IM, Hamre H, Kiserud CE, Loge JH, Fosså SD. Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects. Acta Oncol. 2011;50(5):653-659.
Romerius P, Ståhl O, Moëll C, et al. Sperm DNA integrity in men treated for childhood cancer. Clin Cancer Res. 2010;16(15):3843-3850.
Frisk P, Arvidson J, Neveus T. Glomerular and tubular function in young adults treated with stem-cell transplantation in childhood. Pediatr Nephrol. 2010;25(7):1337-1342.
Fjalldal S, Holmer H, Rylander L, et al. Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metab. 2013;98(8):3253-3262.
Follin C, Thilén U, Österberg K, Björk J, Erfurth EM. Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2010;95(8):3726-3735.
Einarsson EJ, Petersen H, Wiebe T, et al. Long term hearing degeneration after platinum-based chemotherapy in childhood. Int J Audiol. 2010;49(10):765-771.
Jarvela LS, Niinikoski H, Lähteenmäki PM, et al. Physical activity and fitness in adolescent and young adult long-term survivors of childhood acute lymphoblastic leukaemia. J Cancer Surviv. 2010;4(4):339-345.
Pietila S, Korpela R, Lenko HL, et al. Neurological outcome of childhood brain tumor survivors. J Neurooncol. 2012;108(1):153-161.
Ylanen K, Poutanen T, Savikurki-Heikkilä P, Rinta-Kiikka I, Eerola A, Vettenranta K. Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer. J Am Coll Cardiol. 2013;61(14):1539-1547.
Jahnukainen K, Heikkinen R, Henriksson M, Cooper TG, Puukko-Viertomies L-R, Mäkitie O. Semen quality and fertility in adult long-term survivors of childhood acute lymphoblastic leukemia. Fertil Steril. 2011;96(4):837-842.
Vatanen A, Ojala TH, Sarkola T, et al. Left ventricular mass and ambulatory blood pressure are increased in long-term survivors of childhood cancer after autologous SCT. Bone Marrow Transplant. 2016;51(6):853-855.
Remes TM, Arikoski PM, Lähteenmäki PM, et al. Bone mineral density is compromised in very long-term survivors of irradiated childhood brain tumor. Acta Oncol. 2018;57(5):665-674.
Einar-Jon E, Trausti O, Asgeir H, et al. Hearing impairment after platinum-based chemotherapy in childhood. Pediatr Blood Cancer. 2011;56(4):631-637.
Järvela LS, Niinikoski H, Lähteenmäki PM, et al. Physical activity and fitness in adolescent and young adult long-term survivors of childhood acute lymphoblastic leukaemia. J Cancer Surviv. 2010;4(4):339-345.
Romerius P, Ståhl O, Moëll C, et al. Sperm DNA integrity in men treated for childhood cancer. Clin Cancer Res. 2010;16(15):3843-3850.
Norsker FN, Rechnitzer C, Andersen EW, et al. Neurologic disorders in long-term survivors of neuroblastoma - a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) research program. Acta Oncol. 2020;59(2):134-140.
Termuhlen AM, Tersak JM, Liu Q, et al. Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2011;57(7):1210-1216.
Mody R, Li S, Dover DC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood. 2008;111(12):5515-5523.
Wilhelmsson M, Glosli H, Ifversen M, et al. Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study. Bone Marrow Transplant. 2019;54(5):726-736.
Armstrong GT, Liu Q, Yasui Y, et al. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2009;101(13):946-958.
Moyer KH, Willard VW, Gross AM, et al. The impact of attention on social functioning in survivors of pediatric acute lymphoblastic leukemia and brain tumors. Pediatr Blood Cancer. 2012;59(7):1290-1295.
Puhr A, Ruud E, Anderson V, et al. Self-reported executive dysfunction, fatigue, and psychological and emotional symptoms in physically well-functioning long-term survivors of pediatric brain tumor. Dev Neuropsychol. 2019;44(1):88-103.
Rosenberg AR, Postier A, Osenga K, et al. Long-term psychosocial outcomes among bereaved siblings of children with cancer. J Pain Symptom Manage. 2015;49(1):55-65.
Daly A, Lewis RW, Vangile K, et al. Survivor clinic attendance among pediatric- and adolescent-aged survivors of childhood cancer. J Cancer Surviv. 2019;13(1):56-65.
Nathan PC, Agha M, Pole JD, et al. Predictors of attendance at specialized survivor clinics in a population-based cohort of adult survivors of childhood cancer. J Cancer Surviv. 2016;10(4):611-618.
Hudson BF, Oostendorp LJM, Candy B, et al. The under reporting of recruitment strategies in research with children with life-threatening illnesses: a systematic review. Palliat Med. 2017;31(5):419-436.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495-1499.
Winther JF, Kremer L. Long-term follow-up care needed for children surviving cancer: still a long way to go. Lancet Oncol. 2018;19(12):1546-1548.
Dixon SB, Chow EJ, Hjorth L, et al. The future of childhood cancer survivorship: challenges and opportunities for continued progress. Pediatr Clin North Am. 2020;67(6):1237-1251.
Järvela LS, Niinikoski H, Lähteenmäki PM, et al. Physical activity and fitness in adolescent and young adult long-term survivors of childhood acute lymphoblastic leukaemia. J Cancer Surviv. 2010;4(4):339-345.
Follin C, Thilén U, Österberg K, Björk J, Erfurth EM. Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2010;95(8):3726-3735.
Stensvold E, Stadskleiv K, Myklebust TÅ, et al. Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors. Acta Paediatr. 2020;109(9):1875-1886.